Clinical Trials in Tennessee

Showing 9501-9520 of 15,329 trials

Novel Mobile Device Application to Improve Adherence

NCT02904278

The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.

Pediatric Heart Transplant RecipientsPediatric Cardiac TransplantationPediatric Heart Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)26 participantsStarted Aug 2017

Atlanta, Georgia, United States • Boston, Massachusetts, United States • St Louis, Missouri, United States +5 more locations

COMPLETEDNA29 miles

HW006 LATERAL Thoracotomy

NCT02268942

This is a prospective, multi-center,single-arm study that will evaluate the thoracotomy implant technique in up to 145 subjects implanted via thoracotomy with the HeartWare HVAD System and enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs®) protocol and database. All participating centers are current INTERMACS® sites in good standing and follow the INTERMACS® protocol and procedures.

Left Sided Heart Failure

Medtronic Cardiac Rhythm and Heart Failure144 participantsStarted Nov 2014

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +23 more locations

Novel Mobile Device Application to Improve Adherence

HW006 LATERAL Thoracotomy

Find Trials by Condition in Tennessee

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Post Market Surveillance Study of the Wingspan Stent System

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

ImageReady(TM) MR Conditional Pacing System Clinical Study

Safety and Efficacy of PRP for Treatment of Disc Pain

Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

PF-06741086 Multiple Dose Study in Severe Hemophilia

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

A Clinical Trial of IntensiVE Dialysis

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma